Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

August 31, 2002

Conditions
Lung Cancer
Interventions
DRUG

cisplatin

DRUG

docetaxel

Trial Locations (23)

16132

Istituto Nazionale per la Ricerca sul Cancro, Genoa (Genova)

D-69126

Thoraxklinik Rohrbach, Heidelberg

06122

Oncologia Medica - Perugia, Perugia

2545 CH

Leyenburg Ziekenhuis, 's-Gravenhage (Den Haag, the Hague)

5211 NL

Groot Ziekengasthuis 's-Hertogenbosch, 's-Hertogenbosch

1001HV

Vrije Universiteit Medisch Centrum, Amsterdam

1066 CX

Antoni van Leeuwenhoekhuis, Amsterdam

1066 EC

Slotervaart Ziekenhuis, Amsterdam

1091 HA

Onze Lieve Vrouwe Gasthuis, Amsterdam

6800 TA

Longarts Dr. J.M. Smit Rynstate Hospital, Arnhem

3840 AC

Ziekenhuis St Jansdal, Harderwijk

2300 CA

Leiden University Medical Center, Leiden

3435 CM

Sint Antonius Ziekenhuis, Nieuwegein

6532 SZ

Canisius-Wilhelmina Ziekenhuis, Nijmegen

NL-6500 HB

University Medical Center Nijmegen, Nijmegen

3000 CA

University Hospital - Rotterdam Dijkzigt, Rotterdam

5042 AD

Twee Steden Ziekenhuis Vestiging Tilburg, Tilburg

3584 CX

Academisch Ziekenhuis Utrecht, Utrecht

1502 DV

Zaas Medisch Centrum, Zaandam

8000 GK

Sophia Ziekehuis, Zwolle

02-781

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw

S1O 2SJ

Weston Park Hospital, Sheffield

SM2 5PT

Royal Marsden Hospital, Sutton

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00005868 - Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter